STOCK TITAN

Planned insider stock sale for Company (NASDAQ: SOPH) under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A notice under Rule 144 reports a planned sale of 117,541 shares of common stock with an aggregate market value of $583,003.36. The shares relate to an issuer with 67,847,058 shares outstanding and are expected to be sold around 01/09/2026 on NASDAQ through Morgan Stanley Smith Barney LLC.

The securities to be sold consist of 25,500 founder shares acquired on 03/18/2021 and 92,041 shares received as restricted stock units on 01/18/2026. The notice also lists multiple prior 10b5-1 sales for JURGI CAMBLONG between 10/10/2025 and 01/08/2026, each showing the number of common shares sold and gross proceeds. By signing, the person for whose account the sale is made represents that they are not aware of any undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the SOPH Rule 144 notice disclose about planned share sales?

The notice reports a planned sale of 117,541 common shares with an aggregate market value of $583,003.36, to be sold on NASDAQ through Morgan Stanley Smith Barney LLC around 01/09/2026.

How were the SOPH shares in this Rule 144 filing originally acquired?

The securities consist of 25,500 founder shares acquired on 03/18/2021 and 92,041 shares from restricted stock units dated 01/18/2026, both acquired from the issuer.

How many SOPH shares are outstanding according to this Rule 144 filing?

The filing states that there are 67,847,058 common shares outstanding for the issuer at the time of the notice.

What recent 10b5-1 sales for JURGI CAMBLONG are listed in the Rule 144 notice?

The notice lists multiple 10b5-1 sales for JURGI CAMBLONG of common shares between 10/10/2025 and 01/08/2026, each with the date, number of shares sold, and gross proceeds, such as sales on 01/08/2026, 12/30/2025, and 10/30/2025.

What representation does the seller make in this SOPH Rule 144 filing?

The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Which broker will handle the planned SOPH share sale disclosed in the Rule 144 notice?

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker, with sales planned on NASDAQ.
Sophia Genetics Sa

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

350.09M
63.48M
6.46%
48.2%
0.06%
Health Information Services
Healthcare
Link
Switzerland
Rolle